NO20052167L - Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe - Google Patents

Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe

Info

Publication number
NO20052167L
NO20052167L NO20052167A NO20052167A NO20052167L NO 20052167 L NO20052167 L NO 20052167L NO 20052167 A NO20052167 A NO 20052167A NO 20052167 A NO20052167 A NO 20052167A NO 20052167 L NO20052167 L NO 20052167L
Authority
NO
Norway
Prior art keywords
urinary incontinence
diseases
nitrogen
contraceptives
urination
Prior art date
Application number
NO20052167A
Other languages
English (en)
Norwegian (no)
Inventor
Koji Kawai
Kuniaki Kawamura
Naoki Izumimoto
Morihiro Fujimura
Toshikazu Komagata
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO20052167L publication Critical patent/NO20052167L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20052167A 2002-10-09 2005-05-03 Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe NO20052167L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002295616 2002-10-09
PCT/JP2003/012890 WO2004033457A1 (fr) 2002-10-09 2003-10-08 Remedes ou produits preventifs pour la frequence urinaire ou l'incontinence urinaire, et derives de morphinane presentant un groupe heterocylique contenant de l'azote

Publications (1)

Publication Number Publication Date
NO20052167L true NO20052167L (no) 2005-06-16

Family

ID=32089217

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052167A NO20052167L (no) 2002-10-09 2005-05-03 Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe

Country Status (17)

Country Link
US (1) US7320984B2 (fr)
EP (1) EP1555266B1 (fr)
JP (1) JP4016986B2 (fr)
KR (1) KR101060629B1 (fr)
CN (1) CN100537573C (fr)
AU (1) AU2003272944B2 (fr)
BR (1) BR0314754A (fr)
CA (1) CA2501389C (fr)
ES (1) ES2479042T3 (fr)
HK (1) HK1079786B (fr)
IL (1) IL166944A (fr)
MA (1) MA27454A1 (fr)
MX (1) MXPA05003723A (fr)
NO (1) NO20052167L (fr)
NZ (1) NZ539199A (fr)
WO (1) WO2004033457A1 (fr)
ZA (1) ZA200502650B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060177381A1 (en) * 2002-02-15 2006-08-10 Howard Brooks-Korn Opiopathies
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
TW200533355A (en) 2004-03-30 2005-10-16 Toray Industries Antipruritic agent
PE20060723A1 (es) * 2004-11-04 2006-08-29 Toray Industries Derivados de morfina como agentes analgesicos
JPWO2006104280A1 (ja) * 2005-03-31 2008-09-11 武田薬品工業株式会社 糖尿病の予防・治療剤
WO2007055184A1 (fr) * 2005-11-09 2007-05-18 Toray Industries, Inc. Agent thérapeutique ou prophylactique pour un trouble fonctionnel de l'intestin
WO2007072749A1 (fr) * 2005-12-21 2007-06-28 Toray Industries, Inc. Agent antitussif
ES2627217T3 (es) 2007-05-21 2017-07-27 Toray Industries, Inc. Partículas micropulverizadas cristalinas
AU2008254039B2 (en) * 2007-05-21 2013-10-24 Toray Industries, Inc. Method for producing pharmaceutical tablet
AU2008283929B2 (en) 2007-08-06 2013-10-10 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
PL2712622T3 (pl) * 2008-05-21 2017-01-31 Ferring B.V. Ulegająca rozpadowi w ustach desmopresyna do zwiększania początkowego okresu snu niezakłócanego przez nokturię
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
CA2740476C (fr) * 2008-10-24 2016-04-05 Toray Industries, Inc. Comprime stable contenant un derive de 4,5-epoxymorphinane
WO2010083384A2 (fr) * 2009-01-16 2010-07-22 Virginia Commonwealth University Antagonistes non peptidiques, puissants et sélectifs des récepteurs opioïdes mu
US8623888B2 (en) * 2009-07-15 2014-01-07 Mallinckrodt Llc 3-oxy-hydromorphone derivatives
EP2580201B1 (fr) 2010-06-11 2017-08-02 Rhodes Technologies Procédés catalysés par métal de transition pour la préparation de composés de n-allyle et utilisation de ceux-ci
US10988481B2 (en) 2016-05-19 2021-04-27 Virginia Commonwealth University Potent and selective mu opioid receptor modulators
DK3761982T3 (da) 2018-03-08 2025-01-02 Victoria Link Ltd Anvendelse af nalfurafin til behandling af demyeliniserende sygdomme
CN109970747B (zh) * 2019-05-05 2020-07-24 潍坊科技学院 一种制备10α-羟基纳呋拉啡的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3318884A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 6-amino-6-demethoxythebaine and 6-amino-6-demethoxyoripavine derivatives
ES2121988T3 (es) 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
NZ268969A (en) 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
AU5090796A (en) 1995-03-03 1996-09-23 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
AU6020300A (en) 1999-07-19 2001-02-05 Toray Industries, Inc. Remedies or preventives for frequent urination or urinary incontinence
WO2002080918A1 (fr) 2001-04-02 2002-10-17 Toray Industries, Inc. Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire

Also Published As

Publication number Publication date
IL166944A (en) 2010-11-30
KR101060629B1 (ko) 2011-08-31
US20060040970A1 (en) 2006-02-23
MXPA05003723A (es) 2005-09-30
EP1555266B1 (fr) 2014-05-21
JPWO2004033457A1 (ja) 2006-04-27
WO2004033457A1 (fr) 2004-04-22
JP4016986B2 (ja) 2007-12-05
CA2501389C (fr) 2013-01-08
AU2003272944A1 (en) 2004-05-04
NZ539199A (en) 2008-09-26
AU2003272944B2 (en) 2009-11-12
EP1555266A4 (fr) 2006-12-06
CN1703415A (zh) 2005-11-30
US7320984B2 (en) 2008-01-22
HK1079786A1 (zh) 2006-04-13
HK1079786B (zh) 2010-03-12
ZA200502650B (en) 2006-06-28
KR20050056232A (ko) 2005-06-14
CN100537573C (zh) 2009-09-09
MA27454A1 (fr) 2005-07-01
BR0314754A (pt) 2005-07-26
CA2501389A1 (fr) 2004-04-22
EP1555266A1 (fr) 2005-07-20
ES2479042T3 (es) 2014-07-23

Similar Documents

Publication Publication Date Title
NO20052167L (no) Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe
NO20044974L (no) Imidazo [1,2-a]pyrazin-8-ylaminer, fremgangsmater for fremstilling og anvendelse derav
NO20060972L (no) Pyridylderivater og deres anvendelse som terapeutiske midler
WO1991019497A1 (fr) Inhibition de maladies induites par des voies de 5-lipoxygenase et de cyclooxygenase
ATE227727T1 (de) Thienotriazolodiazepinverbindungen und ihre medizinischen anwendungen
IS7709A (is) Pýrasóló[3,4-b]pýridín efnasambönd, og notkun þeirra sem fosfórdíesterasa hindrar
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
DK1533292T3 (da) Dibenzylaminforbindelse og medicinsk anvendelse deraf
MX2007003321A (es) Derivados heterociclicos y su uso como agentes terapeuticos.
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
JO2282B1 (en) Oxazole derivatives
WO2005011654A3 (fr) Derives de pyridyle et utilisation de ceux-ci en tant qu'agents therapeutiques
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
ATE402175T1 (de) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
NO20055655L (no) Anvendelse av azetidinkarboksamidderivater i terapi
MXPA03008134A (es) Compuesto de n-fenilarilsulfonamida, medicamento que contiene el compuesto como ingrediente activo, intermediario para el compuesto y procedimientos para su produccion.
TW200619212A (en) Morpholine derivatives
EA200400545A1 (ru) Новые замещенные 4-фенил-4-[1h-имидазол-2-ил] пиперидиновые производные и их применение в качестве селективных непептидных агонистов дельта-опиоидов
NZ533795A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
NO20006507L (no) Propenyl kefalosporinderivater
NO20013408L (no) Anvendelse av 2-substituerte 1,2-benzisotiazol-derivater og 3- substituerte tetrahydropyridopyrimidinon-derivater for profylakseog terapi av cerebral ischemi
EP2266566A3 (fr) Dérivés de nicotinamide et utilisation de ceux-ci comme agents thérapeutiques
TW200513463A (en) Agents for treatment or prevention of frequent urination and urinary incontinence and morphinan derivatives having a nitrogen-containing cyclic substituent
EP1433479B8 (fr) Agents stimulant l'appetit et remedes contre l'anorexie

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application